Form 8-K Panbela Therapeutics, For: Mar 05
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/21/2026
- Wall St set for higher open but weekly losses loom
- UBS says bull market has further to run
- S&P 500 may pull back before midterms, but Citi says buy the dip
- Global yield relief evaporates as U.S. rates push back toward multi-decade peaks
- BofA's Hartnett sees dollar slump, risk selloff if bond intervention fails
- Wall Street sinks as bond yields rise, Walmart results disappoint
- Wolfe remains "broadly bullish on AI semis stocks", names Top Pick
- Supermicro probe finds no senior management link to export violations
- SpaceX shares fall as second lockup period ends
- Hertz Global amends voting agreement with CK Amarillo after lawsuit
Panbela Therapeutics Inc. (PBLA) Receives Nasdaq Delisting Determination
March 7, 2024 6:13 AM ESTOn March 5, 2024, The Nasdaq Stock Market LLC (Nasdaq) notified Panbela Therapeutics Inc. (NASDAQ: PBLA) that the Nasdaq Hearings Panel (the Panel) has determined to delist the Companys common stock and that trading of the Companys securities will be suspended at the open of trading on March 7, 2024.... More
